Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2008

01-07-2008 | Hepatic and Pancreatic Tumors

A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals

Authors: Unal Aydin, MD, Suleyman Yedibela, MD, Pinar Yazici, MD, Bulent Aydinli, MD, Murat Zeytunlu, MD, Murat Kilic, MD, Ahmet Coker, MD

Published in: Annals of Surgical Oncology | Issue 7/2008

Login to get access

Abstract

Background

Radical operation for hilar cholangiocellular carcinoma, including extended hepatic resection, seems to improve prognosis by increasing the surgical curability rate. Nevertheless, high postoperative morbidity and mortality have been reported in patients with obstructive jaundice. We describe the technique of “high hilar resection” and a modification of bilioenteric anastomosis for drainage of the multiple secondary or tertiary biliary radicals.

Methods

Ten patients with advanced hilar cholangiocellular carcinoma underwent a high hilar resection with complete parenchymal preservation, and the biliary drainage was reconstructed by a sheath-to-enteric hepaticojejunostomy. Because of the technical difficulty caused by anastomosis line in the range of the biliary sheath, a modification was performed by dividing the biliary apertures of segments 5 and 4b.

Results

A high hilar resection was successfully performed, and all patients were discharged from the hospital in good condition. No patient died postoperatively. The proximal resection margin was tumor-free in all patients. One patient died after 29 months of peritoneal carcinomatosis. None of the patients developed local recurrence around the hepaticojejunostomy. The remaining nine patients are alive after a mean follow-up of 28.8 months after surgery without any signs of recurrence.

Conclusion

In highly selected patients with advanced hilar cholangiocellular carcinoma, a high hilar resection is technically safe and oncologically justifiable. In combination with our new technique of sheath-to-enteric anastomosis, the patients considerably benefit from the preservation of liver parenchyma with low postoperative morbidity and very short in-hospital stay.
Literature
1.
go back to reference Vautey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109–14. Vautey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109–14.
2.
go back to reference Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocellular carcinoma: consensus document. Gut 2002; 51:1–9.CrossRef Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocellular carcinoma: consensus document. Gut 2002; 51:1–9.CrossRef
3.
go back to reference Bismuth H, Nakache R, Diamont T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31–8.PubMedCrossRef Bismuth H, Nakache R, Diamont T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31–8.PubMedCrossRef
4.
go back to reference Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience. Ann Surg 2000; 232:166–74.PubMedCrossRef Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience. Ann Surg 2000; 232:166–74.PubMedCrossRef
5.
go back to reference Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84–92.PubMedCrossRef Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84–92.PubMedCrossRef
6.
go back to reference Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507–19.PubMedCrossRef Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507–19.PubMedCrossRef
7.
go back to reference Silva MA, Tekin K, Aytekin F, et al. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. EJSO 2005; 31:533–9.PubMedCrossRef Silva MA, Tekin K, Aytekin F, et al. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. EJSO 2005; 31:533–9.PubMedCrossRef
8.
go back to reference Jarnagin WR, Bownw W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241:703–14.PubMedCrossRef Jarnagin WR, Bownw W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241:703–14.PubMedCrossRef
9.
go back to reference Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th edition. Tokyo: Kanehara. 2000. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th edition. Tokyo: Kanehara. 2000.
10.
go back to reference Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990; 159:91–8.PubMedCrossRef Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990; 159:91–8.PubMedCrossRef
11.
go back to reference Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors; analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124:1275–9.PubMed Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors; analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124:1275–9.PubMed
12.
go back to reference Sugiura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994; 115:445–51.PubMed Sugiura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994; 115:445–51.PubMed
13.
go back to reference Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73–83.PubMedCrossRef Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73–83.PubMedCrossRef
14.
go back to reference Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12:39–47.PubMedCrossRef Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12:39–47.PubMedCrossRef
15.
go back to reference Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575–83.PubMedCrossRef Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575–83.PubMedCrossRef
16.
go back to reference Nagino M, Kamiya J, Arai T, et al. “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilöar cholangiocarcinoma. Ann Surg 2006; 243:28–32.PubMedCrossRef Nagino M, Kamiya J, Arai T, et al. “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilöar cholangiocarcinoma. Ann Surg 2006; 243:28–32.PubMedCrossRef
17.
go back to reference Baton O, Azoulay D, Adam DVR, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204:250–60.PubMedCrossRef Baton O, Azoulay D, Adam DVR, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204:250–60.PubMedCrossRef
18.
go back to reference Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663–71.PubMedCrossRef Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663–71.PubMedCrossRef
19.
go back to reference Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006; 93:1488–94.PubMedCrossRef Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006; 93:1488–94.PubMedCrossRef
20.
go back to reference Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13:1505–15.PubMed Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13:1505–15.PubMed
21.
go back to reference Launois B, Jamieson GG. The importance of Glisson’s capsule and its sheath in the intrahepatic approach to resection of the liver. Surg Gynecol Obstet 1992; 174:7–10.PubMed Launois B, Jamieson GG. The importance of Glisson’s capsule and its sheath in the intrahepatic approach to resection of the liver. Surg Gynecol Obstet 1992; 174:7–10.PubMed
22.
go back to reference Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumours. Br J Surg 2007; 94:393–4.PubMedCrossRef Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumours. Br J Surg 2007; 94:393–4.PubMedCrossRef
23.
go back to reference Shigeta H, Nagino M, Kamiya J, et al. Bacteremia after hepatectomy: an analysis of single center, 10-year experience with 407 patients. Langenbecks Arch Surg 2002; 387:117–24.PubMedCrossRef Shigeta H, Nagino M, Kamiya J, et al. Bacteremia after hepatectomy: an analysis of single center, 10-year experience with 407 patients. Langenbecks Arch Surg 2002; 387:117–24.PubMedCrossRef
24.
go back to reference Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 2005; 12:778–85.PubMedCrossRef Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 2005; 12:778–85.PubMedCrossRef
25.
go back to reference Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434–40.PubMedCrossRef Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434–40.PubMedCrossRef
26.
go back to reference Poon RT, Fan ST, Lo CM, et al. Improving perioperative expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240:698–708.PubMedCrossRef Poon RT, Fan ST, Lo CM, et al. Improving perioperative expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240:698–708.PubMedCrossRef
27.
go back to reference Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer; a single-center experience. Ann Surg 1996; 224:628–38.PubMedCrossRef Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer; a single-center experience. Ann Surg 1996; 224:628–38.PubMedCrossRef
28.
go back to reference Neuhaus P, Jonas S, Bechstein WO, et al. Extended resection for hilar cholangiocarcinoma. Ann Surg 1999; 230:808–19.PubMedCrossRef Neuhaus P, Jonas S, Bechstein WO, et al. Extended resection for hilar cholangiocarcinoma. Ann Surg 1999; 230:808–19.PubMedCrossRef
29.
go back to reference Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins. Ann Surg 2004; 240:95–101.PubMedCrossRef Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins. Ann Surg 2004; 240:95–101.PubMedCrossRef
30.
go back to reference Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000; 92:276–82.PubMedCrossRef Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000; 92:276–82.PubMedCrossRef
31.
go back to reference Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925–31.PubMedCrossRef Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925–31.PubMedCrossRef
32.
go back to reference Katz S, Yang R, Rodefeld MJ, et al. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991; 26:401–5.PubMedCrossRef Katz S, Yang R, Rodefeld MJ, et al. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991; 26:401–5.PubMedCrossRef
33.
go back to reference Vane DW, Redlich P, Weber T, et al. Impaired immune function in obstructive jaundice. J Surg Res 1988; 45:287–93.PubMedCrossRef Vane DW, Redlich P, Weber T, et al. Impaired immune function in obstructive jaundice. J Surg Res 1988; 45:287–93.PubMedCrossRef
34.
go back to reference Dinant S, Gerhards MF, Rauws EAJ, et al. Improved outcome of resection of hilar cholangiocarcinoma (klatskin tumor). Ann Surg 2006; 13:872–80.CrossRef Dinant S, Gerhards MF, Rauws EAJ, et al. Improved outcome of resection of hilar cholangiocarcinoma (klatskin tumor). Ann Surg 2006; 13:872–80.CrossRef
35.
go back to reference Kasai M., Kimura S, Asakura Y, et al. Surgical treatment of biliary atresia. J Pediatr Surg 1968; 3:665–75.CrossRef Kasai M., Kimura S, Asakura Y, et al. Surgical treatment of biliary atresia. J Pediatr Surg 1968; 3:665–75.CrossRef
36.
go back to reference Icoz G, Kilic M, Zeytunlu M, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003; 9:575–80.PubMedCrossRef Icoz G, Kilic M, Zeytunlu M, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003; 9:575–80.PubMedCrossRef
Metadata
Title
A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals
Authors
Unal Aydin, MD
Suleyman Yedibela, MD
Pinar Yazici, MD
Bulent Aydinli, MD
Murat Zeytunlu, MD
Murat Kilic, MD
Ahmet Coker, MD
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9926-x

Other articles of this Issue 7/2008

Annals of Surgical Oncology 7/2008 Go to the issue